 NEW YORK, Jan. 21, 2021 PRNewswire -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Obalon Therapeutics, Inc. Obalon or the Company NASDAQ: OBLN in connection with the proposed merger of the Company... 